Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 25 results found. Search for [ SII global vaccines manufacturer ]

Results 1 to 21 of 25
PTI
May 1, 2021
Gen Shavendra Silva, chief of COVID prevention operations, said supply is being delayed from the Serum Institute of India in the wake of the current COVID crisis in the country


BusinessToday.In
April 24, 2021
Addressing the scepticism over Covishield prices, Poonawalla said there was an inaccurate comparison between global prices of the vaccine with India, adding that it is the cheapest COVID-19 vaccine available


Reuters
April 16, 2021
Facing soaring cases and overflowing hospitals after lockdown restrictions were eased, it also abruptly changed the rules to allow it to fast-track vaccine imports, having earlier rebuffed foreign drugmakers like Pfizer


PTI
April 6, 2021
I've had substantial contact with the Serum Institute. India is blessed with having a major manufacturer of global vaccines in India, World Bank President David Malpass said


BusinessToday.In
March 5, 2021
Biden administration recently decided to enforce Defence Production Act, which allowed it to boost vaccine production by blocking export of raw material supplies to other countries


Reuters
March 3, 2021
\"The UK has ordered 100 million doses of AstraZeneca's COVID-19 vaccine, of which 10 million doses will come from the Serum Institute of India,\" a UK government spokesperson told Reuters


PTI
February 25, 2021
Located in the city of Pune in Maharashtra, the SII is the world's largest vaccine manufacturer by volume


BusinessToday.In
January 4, 2021
SII CEO Adar Poonawalla said that the company will start selling the Covishield to the Indian government and GAVI (Global Alliance for Vaccines and Immunisation) nations in the first stage, followed by the private market


Joe C Mathew
December 7, 2020
Both companies have applied for vaccine approval, following which, these companies will be able to supply vaccines to the central government to begin its multi-phase vaccination of Indian residents against the COVID-19


PTI
December 1, 2020
A 40-year-old man who was a volunteer in the third phase of the ''Covidshield'' vaccine trial in Chennai has alleged serious side effects, including a virtual neurological breakdown and impairment of cognitive functions


BusinessToday.In
November 29, 2020
Poonawallathanks PM Modi for visiting the institute; says SII shares his vision and continues to work towards ensuring a safe and secure India. SII may apply for emergency use authorisation of its vaccine in the next two weeks


Reuters
November 28, 2020
Poonawalla said in the next few weeks SII plans to apply for emergency use authorization for AstraZeneca's COVID-19 vaccine candidate that he described as a 'very good' option


PB Jayakumar
November 28, 2020
Serum Institute will have a capacity to make over 2.5 billion doses of vaccines a year as it is currently upscaling the capacity from over 1.6 billion doses  


BusinessToday.In
September 27, 2020
Adar Poonawalla had earlier expressed concerns around production and distribution plans of the coronavirus vaccine. He asked if the Centre had Rs 80,000 crore available with it over next one year to distribute vaccine to Indians


BusinessToday.In
New Delhi, September 16, 2020
COVID-19 to become seasonal? Herd immunity will decide frequency of outbreak, claims studyScientists have predicted that coronavirus will become a seasonal virus in countries with temperate climates only when herd humanity is attained. Until then, public health measures must be followed to curb the spread of the virus, a review published in Frontiers highlighted. Dr Hassan Zaraket of the American University of Beirut in Lebanon, added, \"COVID-19 is here to stay and it will continue to cause...


BusinessToday.In
September 15, 2020
Where the UK has resumed the clinical tests of AstraZeneca's COVID-19 vaccine candidate following a review by the country's drug regulator and an independent safety review committee, trials paused in India, US, and South Africa are yet to resume


BusinessToday.In
September 15, 2020
The head of the world's largest vaccine manufacturer said that the world will need 15 billion doses of the COVID-19 shot if it is a two-dose vaccine


BusinessToday.In
September 3, 2020
The 2020 Fortune 40 under 40 list highlights 40 influential people each in five categories of technology, healthcare, finance, media and entertainment, and government and politics from across the world


Reuters
August 29, 2020
Beximco will be the exclusive supplier in Bangladesh for the vaccine being developed by Serum Institute of India (SII), both companies said in a statement on Friday


Mudit Kapoor
August 26, 2020
Poonawalla's Serum Institute is the largest vaccine maker in the world and at the forefront in the race to make COVID-19 vaccine


PAGES 1 OF 2  12